RE:RE:RE:SBFM up 150% on mRNA oncology news As I noted, everything about SBFM's stock price is kind of ridiculous and is reflective of the bubble not yet being totally popped. Essentially, you have a lot of people wildly speculating on the stock and I suspect many of them actually know they are participating in a bunch of nonsense. But it is profitable nonsense for someone, so it happens. There is no/little connection to reality with SBFM - it is all just a big game. This is not the retail investor we want for TH. TH already has two sizable retail investors involved that I personally know in the stock who are legit long term holders. They own 10% of the stock combined and there are many more like them out there who could potentially be buyers of the stock as well. But you have to find a way to connect with them and TH does not seem to want to do that.
We can debate the specifics of TH's historical IR efforts but there can be no debate that these attempts have failed to support the stock price anywhere near like that of most other similiar stocks, especially as the bubble was flying high.
The SBFM situation also highlights at least part of the problem for TH. Reality does not count for much in markets where SBFM can happen. Normally, or at least at many times during my long career, prompt and deep analysis of legitimate company issues by qualified analysts did much to influence a company's share price. For TH that type of analysis is not happening, at least from sell side analysts, as their incentives are tied mostly to deal making for small companies like this. Plus, in one way or another, TH has apparently managed to sour relationships with almost all the analysts covering the stock. So, the price of TH's stock is being set more by people like the large seller recently who is selling without knowing what the real value of the company is and no has easy way or interest to find out what that might be. Additionally, the new manager of those shares is a very large money manager and no doubt has rules in place that they do not hold such low priced, low market cap stocks like TH. So, even if they wanted to do some work and possibly hold onto the stock, that was never going to happen. When those shares moved from a smaller money manager to a larger money manager, they were going to be sold no matter what.
qwerty22 wrote: They have a market cap of $40mil. So if we value everything in that company at zero do we put the value on good retail engagement at $40 mil?
SPCEO1 wrote: SBFM is totally a retail thing (coupled with other brokers, algos no doubt taking advantage of those retial investors) as best I can tell. And as you can tell, that has some benefits, like when you announce pre-clincial news that sounds interesting, your stock rises by 148% and it trades 154 million shares. Maybe what they a nnounced today will one day translate into something important but it is not all that importantright now. Frankly, it is nuts but it does show how engaged retail is now in many stocks and why perhaps it is not too smart for a tiny company like TH to ignore that sector of the market when TH's share price and market cap make it pretty difficult for institutions to be interested in TH's stock.
There could be some crossover to TH when they announce their phase 1a results but, so far, I have never seen any.
What happened with SBFM today is ridiculous but it is nevertheless real. If US investors could bid up bankrupt companies by hundreds of percents after they filed for bankruptcy and informed the SEC in a public filing that shareholders would likely receive nothing, then anything is possible. There is no longer anything that can be claimed to be impossible in the financial markets - oil can trade at a negative price and trillions in government bods can hold a negative yield for years. Maybe the only thing that is still impossible is for TH to have a meaningful IR effort that is aimed at people who can actually transact in its low market cap, low priced stock.
SS1316 wrote:
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove
Effective Against Multidrug Resistant Cancer Cells
Here's a Toronto Biopharma company that jumped on good news on testing alone, anyone have a take on how this may have and effect on us based on their tech? Or maybe reflect positively on the Canadian biopharma sector? Excuse my ignorance but it occurred to me that maybe people will now be looking for the next Biopharma pending good Cancer news.